Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 5, 2006
[Retinoid therapy for autoimmune diseases]Hiroshi Fukasawa, Hiroyuki Kagechika, Koichi ShudoBiochemical and Biophysical Research Communications|April 12, 2002
Potent and selective partial ecdysone agonist activity of chromafenozide in Sf9 cellsTetsuya Toya, Hiroshi Fukasawa, Akio Masui, et al.Bioorganic & Medicinal Chemistry|April 5, 2011
Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituentKiminori Ohta, Emiko Kawachi, Hiroshi Fukasawa, et al.Biological & Pharmaceutical Bulletin|September 13, 2014
Transdermal administration of aqueous pregabalin solution as a potential treatment option for patients with neuropathic pain to avoid central nervous system-mediated side effectsHiroshi Fukasawa, Hideaki Muratake, Marina Nagae, et al.Bioorganic & Medicinal Chemistry|May 21, 2013
Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structuresYohei Amano, Masayuki Noguchi, Madoka Nakagomi, et al.Journal of Medicinal Chemistry|July 26, 2002
Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actionsBitoku Takahashi, Kiminori Ohta, Emiko Kawachi, et al.Plos One|September 26, 2013
A novel aromatic carboxylic acid inactivates luciferase by acylation of an enzymatically active regulatory lysine residueMadoka Nakagomi, Nobuko Fujimaki, Ai Ito, et al.Biological & Pharmaceutical Bulletin|October 24, 2002
Determination of endogenous levels of retinoic acid isomers in type II diabetes mellitus patients. Possible correlation with HbA1c valuesYuko Yamakoshi, Hiroshi Fukasawa, Toshimasa Yamauchi, et al.Clinical and Experimental Nephrology|November 13, 2010
Aldosterone-induced kidney injury is mediated by NFκB activationSeiichi Fukuda, Chihiro Horimai, Kaori Harada, et al.ACS Chemical Neuroscience|April 18, 2014
Silicon-containing GABA derivatives, silagaba compounds, as orally effective agents for treating neuropathic pain without central-nervous-system-related side effectsHiroshi Fukasawa, Hideaki Muratake, Ai Ito, et al.Pageof 2